High dose of pyridoxine induces IGFBP-3 mRNA expression in MCF-7 cells and its induction is inhibited by the p53-specific inhibitor pifithrin-α

J Nutr Sci Vitaminol (Tokyo). 2011;57(4):280-4. doi: 10.3177/jnsv.57.280.

Abstract

It has been reported that supplementation with high-dose vitamin B(6) (B(6)) exerts antitumor effects in rodent models of cancer. However, the mechanism of these effects remains poorly understood. High-dose B(6) also suppresses cell proliferation and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Based on preliminary experiments using DNA microarray analyses, we hypothesized that high-dose pyridoxine (PN) might induce IGF-binding protein-3 (IGFBP-3) expression in MCF-7 cells. In this study, we investigated IGFBP-3 induction by 3 or 10 mM PN using a quantitative real-time PCR method. We found that the induction reached a maximum of 24-fold with 10 mM PN for 72 h compared with non-treated cells. The induction of IGFBP-3 by PN was inhibited by a p53-specific inhibitor, pifithrin-α, in a dose-dependent manner, but was not affected by PD169316 (MAPK inhibitor), AS601245 (c-Jun N-terminal kinase inhibitor) or SL327 (MEK1/2 inhibitor). High-dose PN did not induce p53 mRNA expression. The IGFBP-3 induction by PN seemed to be related to p53 activation.

MeSH terms

  • Acetonitriles / pharmacology
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Apoptosis / drug effects
  • Benzothiazoles / pharmacology
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / metabolism*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Dietary Supplements
  • Dose-Response Relationship, Drug
  • Female
  • Gene Expression / drug effects*
  • Humans
  • Imidazoles / pharmacology
  • Insulin-Like Growth Factor Binding Protein 3 / genetics
  • Insulin-Like Growth Factor Binding Protein 3 / metabolism*
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Oligonucleotide Array Sequence Analysis
  • Pyridoxine / administration & dosage
  • Pyridoxine / pharmacology*
  • Pyridoxine / therapeutic use
  • RNA, Messenger / biosynthesis
  • Real-Time Polymerase Chain Reaction
  • Toluene / analogs & derivatives
  • Toluene / pharmacology
  • Tumor Suppressor Protein p53 / antagonists & inhibitors
  • Tumor Suppressor Protein p53 / metabolism*
  • Vitamin B Complex / administration & dosage
  • Vitamin B Complex / pharmacology*
  • Vitamin B Complex / therapeutic use

Substances

  • 1,3-benzothiazol-2-yl(2-((2-(3-pyridinyl)ethyl)amino)-4-pyrimidinyl)acetonitrile
  • Acetonitriles
  • Antineoplastic Agents
  • Benzothiazoles
  • Imidazoles
  • Insulin-Like Growth Factor Binding Protein 3
  • RNA, Messenger
  • Tumor Suppressor Protein p53
  • Vitamin B Complex
  • Toluene
  • pifithrin
  • Mitogen-Activated Protein Kinases
  • 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole
  • Pyridoxine